110 likes | 122 Views
Global Cancer Biomarkers Market Size, Share, Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2015-2022
E N D
GLOBAL CANCER BIOMARKERS MARKET RESEARCH AND ANALYSIS 2015-2022
DEFINITION Cancer biomarkers are one of the ideal ways to diagnose cancer at early stage. These biomarkers can be present in a range of cell lines, tissues and fluids, which results in response to the presence of cancer.
MARKET MOTIVATORS • Rising prevalence of cancer • Growing usage of cancer biomarkers in drug discovery & development • Technological advancements • FDA support for development of biomarkers • Improved accuracy & speed of diagnosis • Increasing research related to cancer biomarkers
MARKET RESTRAINTS • Low benefit-cost ratio and high capital investment • Lack of regulatory & reimbursement systems • Technical issues related to sample storage and collection
MARKET OPPORTUNITIES • Rising demand from emerging economies • Growing trend towards personalized medicine • Companion diagnostics
MARKET SEGMENTATION BY TUMOR TYPE • Lung cancer • Prostate cancer • Breast cancer • Colorectal cancer • Cervical cancer • Other cancers
MARKET SEGMENTATION BY APPLICATION • Drug discovery & development • Diagnosis • Risk assessment • Prognostics • Others
MARKET PLAYERS • Merck & co. Inc. • QIAGEN N.V. • Agilent Technologies, Inc. • Novartis International AG • Pfizer Inc. To Be Continued……
FOR MORE DETAILS PLEASE VISIT OUR WEBSITE Orion Market Research Pvt. Ltd. (OMR Global) 116, Shagun Arcade, Vijay Nagar Square, Indore, Madhya Pradesh India- 452010 +91-7803040404 +1-6467557667 info@omrglobal.com www.omrglobal.com https://www.omrglobal.com/industry-reports/cancer-biomarkers-market/